These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3580575)
21. Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Preston FE; Laidlaw ST; Sampson B; Kitchen S Br J Haematol; 2002 Mar; 116(3):619-24. PubMed ID: 11849221 [TBL] [Abstract][Full Text] [Related]
22. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans. Ettingshausen CE; Veldmann A; Beeg T; Schneider W; Jäger G; Kreuz W Semin Thromb Hemost; 1999; 25(6):537-41. PubMed ID: 10632475 [TBL] [Abstract][Full Text] [Related]
23. Immunoaffinity purification of protein C by using conformation-specific monoclonal antibodies to protein C-calcium ion complex. Nakamura S; Sakata Y Biochim Biophys Acta; 1987 Aug; 925(2):85-93. PubMed ID: 3620498 [TBL] [Abstract][Full Text] [Related]
24. Protein C in human plasma determined by homogeneous enzyme immunoassay with use of a centrifugal analyzer. Shimamoto M; Yoshimura T; Kimura N; Kita M; Hoshino N; Motoi S; Suehisa E; Nishimura K; Hayashi C; Miyai K Clin Chem; 1988 Sep; 34(9):1834-8. PubMed ID: 3046778 [TBL] [Abstract][Full Text] [Related]
25. An enzyme immunoassay (ELISA) for the quantitation of human factor VII. Boyer C; Wolf M; Rothschild C; Migaud M; Amiral J; Mannucci PM; Meyer D; Larrieu MJ Thromb Haemost; 1986 Dec; 56(3):250-5. PubMed ID: 2436328 [TBL] [Abstract][Full Text] [Related]
26. Discrimination of normal and abnormal prothrombin and protein C in plasma using a calcium ion-inhibited monoclonal antibody to a common epitope on several vitamin K-dependent proteins. Church WR; Bhushan FH; Mann KG; Bovill EG Blood; 1989 Nov; 74(7):2418-25. PubMed ID: 2804372 [TBL] [Abstract][Full Text] [Related]
27. The binding energy of human coagulation protein C to acidic phospholipid vesicles contains a major contribution from leucine 5 in the gamma-carboxyglutamic acid domain. Zhang L; Castellino FJ J Biol Chem; 1994 Feb; 269(5):3590-5. PubMed ID: 8106403 [TBL] [Abstract][Full Text] [Related]
28. Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency. Lay AJ; Donahue D; Tsai MJ; Castellino FJ Blood; 2007 Mar; 109(5):1984-91. PubMed ID: 17047151 [TBL] [Abstract][Full Text] [Related]
29. Properties of recombinant chimeric human protein C and activated protein C containing the gamma-carboxyglutamic acid and trailing helical stack domains of protein C replaced by those of human coagulation factor IX. Christiansen WT; Castellino FJ Biochemistry; 1994 May; 33(19):5901-11. PubMed ID: 8180219 [TBL] [Abstract][Full Text] [Related]
30. A novel ELISA for mouse activated protein C in plasma. Fernández JA; Lentz SR; Dwyre DM; Griffin JH J Immunol Methods; 2006 Jul; 314(1-2):174-81. PubMed ID: 16828789 [TBL] [Abstract][Full Text] [Related]
31. Influence of specific gamma-carboxyglutamic acid residues on the integrity of the calcium-dependent conformation of human protein C. Zhang L; Castellino FJ J Biol Chem; 1992 Dec; 267(36):26078-84. PubMed ID: 1464619 [TBL] [Abstract][Full Text] [Related]
32. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII. Geng JP; Castellino FJ Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404 [TBL] [Abstract][Full Text] [Related]
33. Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation. Heeb MJ; Mosher D; Griffin JH Blood; 1989 Feb; 73(2):455-61. PubMed ID: 2521800 [TBL] [Abstract][Full Text] [Related]
34. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity. Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979 [TBL] [Abstract][Full Text] [Related]
35. A gamma-carboxyglutamic acid (gamma) variant (gamma 6D, gamma 7D) of human activated protein C displays greatly reduced activity as an anticoagulant. Zhang L; Castellino FJ Biochemistry; 1990 Dec; 29(48):10828-34. PubMed ID: 2125495 [TBL] [Abstract][Full Text] [Related]
36. A qualitative and quantitative analysis of the activation and inactivation of protein C in vivo in a primate model. Hoogendoorn H; Nesheim ME; Giles AR Blood; 1990 Jun; 75(11):2164-71. PubMed ID: 2346780 [TBL] [Abstract][Full Text] [Related]
37. Activated protein C assays: A review. Oto J; Fernández-Pardo Á; Miralles M; Plana E; España F; Navarro S; Medina P Clin Chim Acta; 2020 Mar; 502():227-232. PubMed ID: 31730817 [TBL] [Abstract][Full Text] [Related]
38. Functions of individual gamma-carboxyglutamic acid (Gla) residues of human protein c. Determination of functionally nonessential Gla residues and correlations with their mode of binding to calcium. Christiansen WT; Tulinsky A; Castellino FJ Biochemistry; 1994 Dec; 33(50):14993-5000. PubMed ID: 7999756 [TBL] [Abstract][Full Text] [Related]
39. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va. Nishioka J; Ido M; Hayashi T; Suzuki K Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576 [TBL] [Abstract][Full Text] [Related]
40. Fast functional protein C assay using Protac, a novel protein C activator. Martinoli JL; Stocker K Thromb Res; 1986 Aug; 43(3):253-64. PubMed ID: 3526629 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]